Sonidegib, a Smoothened Inhibitor, Promotes Apoptosis and Suppresses Proliferation of Natural Killer/T-Cell Lymphoma.
- Published in:
- Medical Science Monitor, 2019, v. 25, p. 8579, doi. 10.12659/MSM.918812
- By:
- Publication type:
- Article
Works by Li, Chuntuan
Results: 8
1
2
Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
- Published in:
- Drug Design, Development & Therapy, 2017, v. 11, p. 1115, doi. 10.2147/DDDT.S132092
- By:
- Publication type:
- Article
3
The dual PI3K/mTOR inhibitor NVP-BEZ235 inhibits proliferation and induces apoptosis of burkitt lymphoma cells.
- Published in:
- Cancer Cell International, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12935-015-0213-1
- By:
- Publication type:
- Article
4
Combined targeting of Hedgehog/GLI1 and Wnt/β‐catenin pathways in mantle cell lymphoma.
- Published in:
- Hematological Oncology, 2024, v. 42, n. 5, p. 1, doi. 10.1002/hon.3305
- By:
- Publication type:
- Article
5
PDLIM1, a novel miR-3940-5p target, regulates the malignant progression of diffuse large B-cell lymphoma.
- Published in:
- Cancer Biology & Therapy, 2024, v. 25, n. 1, p. 1, doi. 10.1080/15384047.2024.2429175
- By:
- Publication type:
- Article
6
Role of IRF4 in mediating plasmablast differentiation in diffuse large B-cell lymphomas via mTORC1 pathway.
- Published in:
- Annals of Hematology, 2025, v. 104, n. 4, p. 2449, doi. 10.1007/s00277-025-06273-6
- By:
- Publication type:
- Article
7
Role and mechanism of PTEN in Burkitt's lymphoma.
- Published in:
- Oncology Reports, 2020, v. 43, n. 2, p. 481, doi. 10.3892/or.2020.7457
- By:
- Publication type:
- Article
8
FLT3 inhibitors in acute myeloid leukemia.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0675-4
- By:
- Publication type:
- Article